1. Introduction {#sec0005}
===============

Ectopic pancreas is defined as the presence of pancreatic material in tissues where it is normally absent, that has no anatomic, vascular or ductal continuity with the orthotopic gland \[[@bib0005]\]. Although the exact pathogenesis remains unknown, multiple theories attempt to explain its embryological origin, the most prevalent of which being the misplacement theory. According to the misplacement theory, fragments of pancreatic tissue deposit onto adjacent loci during organogenesis and later develop into mature elements \[[@bib0010]\]. This theory may explain the majority of cases in which the ectopic pancreatic tissue is located in other organs derived from the primitive foregut, but it does not explain other occurrences like in Meckel's diverticulum or the colon \[[@bib0015],[@bib0020]\]. Alternative theories include the metaplasia theory, according to which endodermal tissues migrate to the submucosa during embryogenesis and develop into pancreatic tissue \[[@bib0005],[@bib0020]\] and the totipotent theory in which totipotent endodermal cells lining the gut differentiate into pancreatic tissue \[[@bib0005],[@bib0020],[@bib0025]\].

Structurally the ectopic pancreatic tissue resembles the orthotopic pancreas in gross and microscopic anatomy and appears as a firm, intramural nodular mass \[[@bib0005],[@bib0030]\]. A classification system initially developed by Heinrich in 1909 and later modified by Fuentes in 1973 \[[@bib0035]\], divides the ectopic pancreatic tissue into four histologic types ([Table 1](#tbl0005){ref-type="table"}).Table 1Original and modified histologic classification of heterotopic pancreatic tissue.Table 1TypeHistologic features (Heinrich)Histologic features (modified by Fuentes)Type 1Normal pancreatic tissue components present, including acini, ducts and islets of LangerhansNormal pancreatic tissue components present, including acini, ducts and islets of LangerhansType 2Incomplete or lobular arrangement (few acini and multiple ducts). Absence of endocrine elements.Presence of ducts only.Type 3Presence of ducts; acini and islet cells are absent.Exocrine pancreas - acini only.Type 4--Endocrine pancreas - islet cells only.

Most lesions are unifocal (80%) and up to 80% are reported to be less than 3 cm in size \[[@bib0040]\]. Its prevalence in autopsies ranges from 0.55% to 13.7% \[[@bib0010]\]. Literature suggests that the most frequent site is the stomach with a prevalence ranging from 38% to 86%, with duodenum (36%) and proximal jejunum (16%) also being common sites of presentation. Other less common locations include Meckel's diverticulum and ileum \[[@bib0030],[@bib0045],[@bib0050]\] while extra-digestive locations have also been described. Although ectopic pancreatic tissues are usually asymptomatic and are discovered as incidental findings, they may present symptoms, the most common of which are nausea and vomiting (27%), epigastric pain (27%) and weight loss (18%) \[[@bib0055]\] as well as a variety of less common symptoms depending on their location, such as gastric obstruction by a pyloric mass, intussusception of a jejunal lesion or biliary obstruction by a lesion at the ampulla of Vater. The most common complaint is abdominal pain.

In this case report, we present the case of a woman with a gastric ectopic pancreatic tissue located incidentally during a laparoscopic appendectomy in our community hospital, showcasing the management process of this unexpected perioperative finding.

2. Presentation of case {#sec0010}
=======================

A 32 year-old woman with no significant medical history was admitted to our hospital presenting symptoms of lower abdominal quadrant pain. Physical examination revealed a soft abdomen with tenderness located at the right iliac fossa. Blood tests showed a mild leucocytosis and a moderate elevation of C-reactive protein. The diagnosis of appendicitis was confirmed with an ultrasound of the lower abdomen.

A decision was made to proceed with an immediate laparoscopic appendectomy. During the exploration of the abdominal cavity, a pre-pyloric 3 cm mass was located along the greater curvature of the stomach. An appendectomy was performed and the decision to investigate the mass postoperatively was made.

A subsequent computed tomography (CT) scan showed a homogenously enhancing mass of 12.7 × 12.7 mm ([Fig. 1](#fig0005){ref-type="fig"}), while an upper esophago-gastro-duodenoscopy (EGD) showed a partially exophytic lesion on the greater gastric curvature ([Fig. 2](#fig0010){ref-type="fig"}). The presence of the mass was confirmed in an upper GI endoscopic ultrasound ([Fig. 3](#fig0015){ref-type="fig"}). Fine needle biopsy was inconclusive, showing aspecific inflammatory cells. In this setting, a decision to return to the operating theatre was made, in order to perform a laparoscopic wedge resection for diagnostic and therapeutic purposes. The postoperative period was uneventful and the patient was discharged on day 3 \[[@bib0085]\].Fig. 1Abdominal CT scan showing the pre-pyloric, homogenously enhancing mass. The lesion has similar appearance as the nearby normal pancreatic tissue.Fig. 1Fig. 2Esophagogastroduodenoscopy image demonstrating the partially exophytic lesion near the great gastric curvature.Fig. 2Fig. 3Endoscopic ultrasound image showing the hypoechoic mass of 17.4 mm × 14.8 mm.Fig. 3

Histopathologic examination revealed a heterotopic pancreatic tissue within the gastric wall ([Fig. 4](#fig0020){ref-type="fig"}) with normal pancreatic tissue components present, including acini, ducts and islets of Langerhans.Fig. 4Histopathology showing pancreatic acinar cells and pancreatic ducts in the ectopic pancreatic tissue.Fig. 4

3. Discussion {#sec0015}
=============

To this day the management of ectopic pancreas poses a medical challenge. Although an abundance of information on the nature of the disease exists in the literature, as well as pertinent statistical data (prevalence, lesion location, malignancy potential, diagnostic efficacy of radiologic tools, etc.) the source of this knowledge is mainly case reports or retrospective studies of small patient pools, resulting into great statistical variance and inconsistency.

Despite the evolution of diagnostic modalities, there is no golden standard for the diagnosis of this lesion nor a defined protocol to facilitate it exists. The diagnostic quiver consists of radiologic exams and endoscopy, in combination with a direct biopsy of the lesion.

Radiologic tools that may be employed include upper GI series (UGI), ultrasound (US) and endoscopic ultrasound (EUS), computed tomography (CT), magnetic resonance imaging (MRI) and MR cholangiopancreatography (MRCP). Radiologic findings in UGI, US and CT are well defined, while documentation of ectopic pancreatic tissue characteristics in MRI remain limited \[[@bib0060]\]. Despite of the many modalities available, radiologic tools may be suggestive of the diagnosis, but remain unable to preclude an invasive diagnostic procedure.

Gottschalk U et al. mention in their study that the use of EUS, although helpful in the diagnosis of subepithelial lesions, has limited efficacy in differentiating an ectopic pancreas from other lesions with similar appearance such as gastrointestinal stroll tumours (GISTs), submucosal neuroendocrine tumours, hamartomas and schwannomas. They also note a discordance in literature regarding the echographic characteristics of the ectopic pancreas \[[@bib0065]\]. A potential advantage of EUS is the ability to perform a fine-needle biopsy.

Endoscopy of the upper GI tract is a tool with high sensitivity but low specificity for the diagnosis of ectopic pancreas. In EGD, the ectopic pancreatic rest appears as a submucosal mass with endoluminal growth pattern, while central umbilication can be noticed owning to the presence of a rudimentary ductal system. Due to the subepithelial nature of the lesion, superficial endoscopic biopsy is inadequate \[[@bib0005]\].

Current data are unable to indicate a standardised and cost effective diagnostic procedure. Despite the modern imaging capabilities, the basis of the diagnosis of a gastric heterotopia remains the wedge resection of the lesion and histopathologic examination of the specimen \[[@bib0080]\]. Furthermore, there is currently no consensus on a potentially conservative management of a heterotopic pancreatic tissue. On the other hand, ectopic pancreatic tissue can be life-saving for patients who need a total pancreatectomy for cancer or chronic pancreatitis. In this context, it would seem reasonable to leave the ectopic pancreatic tissue in place to prevent a surgery-induced diabetes. An accumulation of non-invasive diagnostic methods could help in the future to identify a pancreatic ectopia and to preserve it in this cohort of patients.

In this case report we present a patient with a pre-pyloric mass incidentally found during a laparoscopic appendectomy. Despite of a series of exams that were performed, the lack of diagnosis posed the indication to return the patient to the operating theatre for a laparoscopic wedge resection of the lesion \[[@bib0070]\].

4. Conclusion {#sec0020}
=============

Heterotopic pancreas is a rare medical entity that is most commonly encountered as an incidental finding during a radiological test or perioperatively \[[@bib0075]\]. Clinical as well as radiological presentation are unspecific and often prove inconclusive, requiring more invasive diagnostic tools to be employed. A pancreatic heterotopia should be included in the differential diagnosis of upper GI tract masses. High clinical suspicion is necessary. At this time, no evidence-based guidelines for the management of a heterotopic pancreatic tissue exist. While the majority of cases are benign, heterotopic pancreatic loci may harbour malignant potential. This case report highlights this rare perioperative incidental finding and the necessity of systematic studies in order to form a consensus on the diagnostic process and management of these lesions.
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